- Home
- TOP vs ITRM Comparison
TOP vs ITRM Comparison
Compare TOP & ITRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TOP
- ITRM
- Stock Information
- Founded
- TOP 2015
- ITRM 2015
- Country
- TOP Singapore
- ITRM Ireland
- Employees
- TOP N/A
- ITRM N/A
- Industry
- TOP Investment Bankers/Brokers/Service
- ITRM Biotechnology: Pharmaceutical Preparations
- Sector
- TOP Finance
- ITRM Health Care
- Exchange
- TOP Nasdaq
- ITRM Nasdaq
- Market Cap
- TOP 43.0M
- ITRM 40.0M
- IPO Year
- TOP 2022
- ITRM 2018
- Fundamental
- Price
- TOP $1.16
- ITRM $0.66
- Analyst Decision
- TOP
- ITRM Strong Buy
- Analyst Count
- TOP 0
- ITRM 2
- Target Price
- TOP N/A
- ITRM $7.00
- AVG Volume (30 Days)
- TOP 22.1K
- ITRM 793.9K
- Earning Date
- TOP 08-13-2025
- ITRM 08-05-2025
- Dividend Yield
- TOP N/A
- ITRM N/A
- EPS Growth
- TOP N/A
- ITRM N/A
- EPS
- TOP N/A
- ITRM N/A
- Revenue
- TOP $3,329,256.00
- ITRM N/A
- Revenue This Year
- TOP N/A
- ITRM N/A
- Revenue Next Year
- TOP N/A
- ITRM $249.35
- P/E Ratio
- TOP N/A
- ITRM N/A
- Revenue Growth
- TOP N/A
- ITRM N/A
- 52 Week Low
- TOP $1.00
- ITRM $0.61
- 52 Week High
- TOP $1.94
- ITRM $3.02
- Technical
- Relative Strength Index (RSI)
- TOP 47.23
- ITRM 38.41
- Support Level
- TOP $1.13
- ITRM $0.61
- Resistance Level
- TOP $1.18
- ITRM $0.70
- Average True Range (ATR)
- TOP 0.03
- ITRM 0.06
- MACD
- TOP 0.00
- ITRM -0.00
- Stochastic Oscillator
- TOP 23.08
- ITRM 16.94
About TOP TOP Financial Group Limited
TOP Financial Group Ltd is an online brokerage firm in Hong Kong specializing in trading local and overseas equities, futures, and options products. The Company generates brokerage commission income by enabling its customers to trade on multiple exchanges present globally. The company operates in only one segment which is the futures brokerage service.
About ITRM Iterum Therapeutics plc
Iterum Therapeutics PLC is a pharmaceutical company dedicated to maximizing the commercial potential of Orlynvah, an oral-branded penem available in the United States and potentially the first and only oral and intravenous (IV) branded penem available globally. Its product Orlynvah has the potential to be a treatment for complicated urinary tract infections caused by the designated microorganisms, without the presence of known toxicities of some other antibiotics. The company operates in a single business segment, which is the development and commercialization of treatments for drug-resistant bacterial infections.